Naoki Taka

538 total citations
24 papers, 436 citations indexed

About

Naoki Taka is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Naoki Taka has authored 24 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 9 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Naoki Taka's work include Synthesis of Organic Compounds (7 papers), Fibroblast Growth Factor Research (4 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Naoki Taka is often cited by papers focused on Synthesis of Organic Compounds (7 papers), Fibroblast Growth Factor Research (4 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Naoki Taka collaborates with scholars based in Japan, United States and South Korea. Naoki Taka's co-authors include Haruhiko Sato, Hiroshi Koga, Hiroharu Matsuoka, Masayuki Ohmori, Nobuya Ishii, Hirosato Ebiike, Yoshito Nakanishi, Kenji Morikami, Hidetoshi Shindoh and Sachiya Ikeda and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and International Journal of Cancer.

In The Last Decade

Naoki Taka

21 papers receiving 363 citations

Peers

Countries citing papers authored by Naoki Taka

Since Specialization

Citations

This map shows the geographic impact of Naoki Taka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Taka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Taka more than expected).

Fields of papers citing papers by Naoki Taka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Taka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Taka. The network helps show where Naoki Taka may publish in the future.

Co-authorship network of co-authors of Naoki Taka

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Taka. A scholar is included among the top collaborators of Naoki Taka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Taka. Naoki Taka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of [5-Amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone (CH5183284/Debio 1347), An Orally Available and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor 2016 ·Journal of Medicinal Chemistry ·Hirosato Ebiike, Naoki Taka, Masayuki Matsushita, Masayuki Ohmori, (unknown), (unknown), (unknown), Tadakatsu Hayase, (unknown), Kenji Morikami, Yoshito Nakanishi, (unknown), Hidetoshi Shindoh, Nobuya Ishii, (unknown), Hiroharu Matsuoka	35
2	The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor 2014 ·Molecular Cancer Therapeutics ·Yoshito Nakanishi, (unknown), Toshiyuki Tsukaguchi, Toshihiko Fujii, Kiyoaki Sakata, Hitoshi Sase, (unknown), Kenji Morikami, Hidetoshi Shindoh, Toshiyuki Mio, Hirosato Ebiike, Naoki Taka, Yuko Aoki, Nobuya Ishii	101
3	Abstract 2729: FGFR genetic alterations as a potential predictor of the sensitivity to CH5183284/Debio 1347, a selective FGFR inhibitor with a novel chemical scaffold 2014 ·Cancer Research ·Yoshito Nakanishi, (unknown), Toshiyuki Tsukaguchi, (unknown), Toshihiko Fujii, Kiyoaki Sakata, Hitoshi Sase, (unknown), Yasuko Sato, Kenji Morikami, Hidetoshi Shindoh, Toshiyuki Mio, Hirosato Ebiike, Naoki Taka, Yuko Aoki, Nobuya Ishii	1
4	Abstract 2533: Design and preclinical profile of CH5183284/Debio 1347, a novel orally available and selective FGFR inhibitor acting on a gatekeeper mutant of FGFR2 2014 ·Cancer Research ·Hirosato Ebiike, Naoki Taka, Yoshito Nakanishi, (unknown), (unknown), Kenji Morikami, Masayuki Matsushita, Masayuki Ohmori, (unknown), (unknown), (unknown), Tadakatsu Hayase, (unknown), Nobuya Ishii, Hiroharu Matsuoka	1
5	C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes 2012 ·Bioorganic & Medicinal Chemistry ·Yoshihito Ohtake, Tsutomu Sato, Hiroharu Matsuoka, Takamitsu Kobayashi, Masahiro Nishimoto, Naoki Taka, Koji Takano, Keisuke Yamamoto, Masayuki Ohmori, Takashi Higuchi, Masatoshi Murakata, Kazumi Morikawa, (unknown), Masayuki Suzuki, Hitoshi Hagita, Kazuharu Ozawa, Koji Yamaguchi, Motohiro Kato, Sachiya Ikeda	13
6	Discovery of Tofogliflozin, a Novel C-Arylglucoside with an O-Spiroketal Ring System, as a Highly Selective Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes 2012 ·Journal of Medicinal Chemistry ·Yoshihito Ohtake, Tsutomu Sato, Takamitsu Kobayashi, Masahiro Nishimoto, Naoki Taka, Koji Takano, Keisuke Yamamoto, Masayuki Ohmori, (unknown), (unknown), (unknown), (unknown), Hiroharu Matsuoka, Kazumi Morikawa, Masayuki Suzuki, Hitoshi Hagita, Kazuharu Ozawa, Koji Yamaguchi, Motohiro Kato, Sachiya Ikeda	136
7	5a-Carba-β-d-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes 2011 ·Bioorganic & Medicinal Chemistry ·Yoshihito Ohtake, Tsutomu Sato, Hiroharu Matsuoka, Masahiro Nishimoto, Naoki Taka, Koji Takano, Keisuke Yamamoto, Masayuki Ohmori, Takashi Higuchi, Masatoshi Murakata, Takamitsu Kobayashi, Kazumi Morikawa, (unknown), Masayuki Suzuki, Hitoshi Hagita, Kazuharu Ozawa, Koji Yamaguchi, Motohiro Kato, Sachiya Ikeda	19
8	Discovery of novel motilin antagonists: Conversion of tetrapeptide leads to orally available peptidomimetics 2009 ·Bioorganic & Medicinal Chemistry Letters ·Naoki Taka, Hiroharu Matsuoka, Tsutomu Sato, Hitoshi Yoshino, (unknown), Haruhiko Sato, (unknown), (unknown), (unknown), Kenichi Ozaki, Atsuko Higashida, Toshio Kuroki	4
9	A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line 2003 ·International Journal of Cancer ·(unknown), Katsura Nozawa, Masaharu Takemura, Shunji Izuta, Takashi Murate, Masayuki Tsuchiya, Kenji Yoshida, Naoki Taka, Yuji Nimura, Shonen Yoshida	16
10	6-Substituted 2,2-Bis(fluoromethyl)-benzopyran-4-carboxamide K+ channel openers 2000 ·Bioorganic & Medicinal Chemistry ·Naoki Taka, Hiroshi Koga, Haruhiko Sato, (unknown), (unknown), Jun‐ichi Imagawa	21
11	Synthesis and vasorelaxant activity of 2-fluoromethylbenzopyran potassium channel openers 1998 ·Bioorganic & Medicinal Chemistry ·(unknown), Hiroshi Koga, Haruhiko Sato, (unknown), Naoki Taka, Jun‐ichi Imagawa	7
12	Synthesis of 2-(Benzopyran-4-yl)pyridine N-Oxide K+ Channnel Opener via Palladium-catalyzed Cross-Coupling Reaction 1995 ·Heterocycles ·Hiroshi Koga, (unknown), Haruhiko Sato, (unknown), Naoki Taka	6
13	Synthesis and vasorelaxant activity of N-imino-2-(benzopyran-4-yl)pyridine K+ channel openers 1994 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Hiroshi Koga, Haruhiko Sato, (unknown), Naoki Taka, Jun‐ichi Imagawa	1
14	Vasorelaxant activity of 2-fluoromethylbenzopyran K+ channel openers 1994 ·Bioorganic & Medicinal Chemistry Letters ·Naoki Taka, Hiroshi Koga, Haruhiko Sato, (unknown), (unknown), Jun‐ichi Imagawa	2
15	ChemInform Abstract: Synthesis and Antihypertensive Activity of KC‐399, a Benzopyran K+ Channel Opener with long duration of Action and less Tachycardia. 1994 ·ChemInform ·(unknown), Haruhiko Sato, Jun‐ichi Imagawa, (unknown), (unknown), (unknown), Naoki Taka, (unknown), Hiroyuki Nabata	1
16	Substituent effects of benzopyran-4-(N-cyano)-carboxamidine potassium channel openers for selectivity to guinea pig trachealis 1994 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Hiroshi Koga, Haruhiko Sato, T. Makino, Naoki Taka, (unknown), Tsutomu Sato, (unknown)	7
17	Benzopyran-4-carboxamide K+ channel openers 1993 ·Bioorganic & Medicinal Chemistry Letters ·Hiroshi Koga, Haruhiko Sato, (unknown), (unknown), T. Makino, Naoki Taka, (unknown), Tsutomu Sato, Hiroyuki Nabata	12
18	Structure-activity relationships of 6-substituted benzopyran-4-carbothioamide potassium channel openers 1993 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Hiroshi Koga, Masateru Ohta, Haruhiko Sato, T. Makino, (unknown), Naoki Taka, (unknown), Tsutomu Sato, (unknown)	12
19	Vasorelaxant activity of 2-substituted 6-nitro-2H-1-benzopyran-4-carbothioamide K+ channel openers 1993 ·Bioorganic & Medicinal Chemistry Letters ·Haruhiko Sato, Hiroshi Koga, (unknown), T. Makino, (unknown), Naoki Taka, (unknown), Tsutomu Sato, (unknown)	10
20	Chirality transfer in the 1,5-hydride shift of a stannyl compound having cationic center at δ-position 1989 ·Tetrahedron Letters ·Tadashi Sato, Masayuki Haramura, Naoki Taka	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact